Raport anual 2014
Spikevax, INN-elasomeran/imelasomeran
Disposition of patients. FAS, full analysis; PPS, per-protocol main... | Download Scientific Diagram
JCOVDEN, INN-Ad26.COV2-S, recombinant
Subject disposition. FAS: full analysis set, PP: per protocol, ITT:... | Download Scientific Diagram
COVID-19 Vaccine Janssen, INN-Ad26.COV2-S, recombinant
Patient disposition. FAS, full analysis set; PPS, per-protocol set. | Download Scientific Diagram
Eylea, INN-Aflibercept
Subject disposition. FAS: full analysis set, PP: per protocol, ITT:... | Download Scientific Diagram
Interval-cohort designs and bias in the estimation of per-protocol effects: a simulation study | Trials | Full Text
COVID-19 Vaccine Janssen, INN-Ad26.COV2-S, recombinant
Patient disposition. FAS, full analysis set; PPS, per-protocol set;... | Download Scientific Diagram
Per-protocol Effect in Randomized Trials | Miguel Hernan's Faculty Website | Harvard T.H. Chan School of Public Health
Patient disposition. FAS, full analysis set; PPS, per-protocol set. | Download Scientific Diagram
Spikevax, INN-elasomeran
Spikevax, INN-COVID-19 mRNA Vaccine (nucleoside modified);
COVID-19 Vaccine Janssen, INN-Ad26.COV2-S, recombinant
Per-protocol Effect in Randomized Trials | Miguel Hernan's Faculty Website | Harvard T.H. Chan School of Public Health
COVID-19 Vaccine Janssen, INN-Ad26.COV2-S, recombinant
Spikevax, INN-elasomeran
Raport 2 Analiza capacității de furnizare de competențe a sistemelor de formare profesională
JCOVDEN, INN-Ad26.COV2-S, recombinant
Eylea, INN-Aflibercept
Study disposition. FAS, full analysis set; PPS, per-protocol set. | Download Scientific Diagram
Interval-cohort designs and bias in the estimation of per-protocol effects: a simulation study | Trials | Full Text
Interval-cohort designs and bias in the estimation of per-protocol effects: a simulation study | Trials | Full Text
Raport al Notei de Fundamentare:
